SlideShare uma empresa Scribd logo
1 de 18
Door: Jaap Schep & Marlot Clarijs
[object Object]
[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
 
 
 
[object Object],[object Object]
[object Object],[object Object]
 
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
[object Object],[object Object]
[object Object],[object Object]
 
[object Object],[object Object],[object Object]
Zijn er nog vragen?

Mais conteúdo relacionado

Mais procurados

Initial Therapy in CLL
Initial Therapy in CLLInitial Therapy in CLL
Initial Therapy in CLLroysudip900
 
Evaluation of preoperative pulmonary risk By Nahid Sherbini
Evaluation of preoperative pulmonary risk By Nahid SherbiniEvaluation of preoperative pulmonary risk By Nahid Sherbini
Evaluation of preoperative pulmonary risk By Nahid SherbiniNahid Sherbini
 
Role of bevacizumab in ca ovary
Role of bevacizumab in ca ovaryRole of bevacizumab in ca ovary
Role of bevacizumab in ca ovarypooja gupta
 
The Latest Treatments for HER2-Positive Breast Cancer
The Latest Treatments for HER2-Positive Breast CancerThe Latest Treatments for HER2-Positive Breast Cancer
The Latest Treatments for HER2-Positive Breast CancerDana-Farber Cancer Institute
 
Brain Metastasis: Emerging Treatments ans Reasons to be Hopeful
Brain Metastasis: Emerging Treatments ans Reasons to be HopefulBrain Metastasis: Emerging Treatments ans Reasons to be Hopeful
Brain Metastasis: Emerging Treatments ans Reasons to be Hopefulbkling
 
Receptor Tyrosine Kinases
Receptor Tyrosine KinasesReceptor Tyrosine Kinases
Receptor Tyrosine Kinasesfondas vakalis
 
Strategies for Managing Recurrent Ovarian Cancer
Strategies for Managing Recurrent Ovarian CancerStrategies for Managing Recurrent Ovarian Cancer
Strategies for Managing Recurrent Ovarian Cancerbkling
 
SERDs in HR+HER2- Breast Cancer
SERDs in HR+HER2- Breast CancerSERDs in HR+HER2- Breast Cancer
SERDs in HR+HER2- Breast CancerPranay Kumar
 
Genome in a Bottle- reference materials to benchmark challenging variants and...
Genome in a Bottle- reference materials to benchmark challenging variants and...Genome in a Bottle- reference materials to benchmark challenging variants and...
Genome in a Bottle- reference materials to benchmark challenging variants and...GenomeInABottle
 
Pharmacogenetics and Warfarin
Pharmacogenetics and WarfarinPharmacogenetics and Warfarin
Pharmacogenetics and WarfarinAndrew Guvetis
 
Herceptin induced cardiotoxicity
Herceptin induced cardiotoxicityHerceptin induced cardiotoxicity
Herceptin induced cardiotoxicityDr Boaz Vincent
 
Endocrine Therapy In Advanced Breast Cancer
Endocrine Therapy In Advanced Breast CancerEndocrine Therapy In Advanced Breast Cancer
Endocrine Therapy In Advanced Breast Cancerguest8887a7
 
Targeted therapy and immunotherapy in lung cancer
Targeted therapy and immunotherapy in lung cancerTargeted therapy and immunotherapy in lung cancer
Targeted therapy and immunotherapy in lung cancerAlok Gupta
 
Kiow 11 2017 metastatic colon cancer from bench to clinic
Kiow 11 2017 metastatic colon cancer from bench to clinicKiow 11 2017 metastatic colon cancer from bench to clinic
Kiow 11 2017 metastatic colon cancer from bench to clinicMohamed Abdulla
 
Anti cancer-drug (Bevacizumab)
Anti cancer-drug (Bevacizumab)Anti cancer-drug (Bevacizumab)
Anti cancer-drug (Bevacizumab)Anwar Parvez
 

Mais procurados (20)

Initial Therapy in CLL
Initial Therapy in CLLInitial Therapy in CLL
Initial Therapy in CLL
 
Evaluation of preoperative pulmonary risk By Nahid Sherbini
Evaluation of preoperative pulmonary risk By Nahid SherbiniEvaluation of preoperative pulmonary risk By Nahid Sherbini
Evaluation of preoperative pulmonary risk By Nahid Sherbini
 
Role of bevacizumab in ca ovary
Role of bevacizumab in ca ovaryRole of bevacizumab in ca ovary
Role of bevacizumab in ca ovary
 
The Latest Treatments for HER2-Positive Breast Cancer
The Latest Treatments for HER2-Positive Breast CancerThe Latest Treatments for HER2-Positive Breast Cancer
The Latest Treatments for HER2-Positive Breast Cancer
 
Brain Metastasis: Emerging Treatments ans Reasons to be Hopeful
Brain Metastasis: Emerging Treatments ans Reasons to be HopefulBrain Metastasis: Emerging Treatments ans Reasons to be Hopeful
Brain Metastasis: Emerging Treatments ans Reasons to be Hopeful
 
Receptor Tyrosine Kinases
Receptor Tyrosine KinasesReceptor Tyrosine Kinases
Receptor Tyrosine Kinases
 
Strategies for Managing Recurrent Ovarian Cancer
Strategies for Managing Recurrent Ovarian CancerStrategies for Managing Recurrent Ovarian Cancer
Strategies for Managing Recurrent Ovarian Cancer
 
Update Nsclc
Update NsclcUpdate Nsclc
Update Nsclc
 
SERDs in HR+HER2- Breast Cancer
SERDs in HR+HER2- Breast CancerSERDs in HR+HER2- Breast Cancer
SERDs in HR+HER2- Breast Cancer
 
Genome in a Bottle- reference materials to benchmark challenging variants and...
Genome in a Bottle- reference materials to benchmark challenging variants and...Genome in a Bottle- reference materials to benchmark challenging variants and...
Genome in a Bottle- reference materials to benchmark challenging variants and...
 
Pharmacogenetics and Warfarin
Pharmacogenetics and WarfarinPharmacogenetics and Warfarin
Pharmacogenetics and Warfarin
 
Chemotherapy hypersensitivity.pdf
Chemotherapy hypersensitivity.pdfChemotherapy hypersensitivity.pdf
Chemotherapy hypersensitivity.pdf
 
Herceptin induced cardiotoxicity
Herceptin induced cardiotoxicityHerceptin induced cardiotoxicity
Herceptin induced cardiotoxicity
 
Endocrine Therapy In Advanced Breast Cancer
Endocrine Therapy In Advanced Breast CancerEndocrine Therapy In Advanced Breast Cancer
Endocrine Therapy In Advanced Breast Cancer
 
Targeted cancer therapies
Targeted cancer therapiesTargeted cancer therapies
Targeted cancer therapies
 
Immune checkpoints sot2016
Immune checkpoints sot2016Immune checkpoints sot2016
Immune checkpoints sot2016
 
Targeted therapy and immunotherapy in lung cancer
Targeted therapy and immunotherapy in lung cancerTargeted therapy and immunotherapy in lung cancer
Targeted therapy and immunotherapy in lung cancer
 
Kiow 11 2017 metastatic colon cancer from bench to clinic
Kiow 11 2017 metastatic colon cancer from bench to clinicKiow 11 2017 metastatic colon cancer from bench to clinic
Kiow 11 2017 metastatic colon cancer from bench to clinic
 
Anti cancer-drug (Bevacizumab)
Anti cancer-drug (Bevacizumab)Anti cancer-drug (Bevacizumab)
Anti cancer-drug (Bevacizumab)
 
Avastin
AvastinAvastin
Avastin
 

Semelhante a De Haven Van Rotterdam

Hv2 h6 §1
Hv2 h6 §1Hv2 h6 §1
Hv2 h6 §1bry_laky
 
S&O Marleen van de Kerkhof Duurzaamheid Engineeringweek Hogeschool van Amsterdam
S&O Marleen van de Kerkhof Duurzaamheid Engineeringweek Hogeschool van AmsterdamS&O Marleen van de Kerkhof Duurzaamheid Engineeringweek Hogeschool van Amsterdam
S&O Marleen van de Kerkhof Duurzaamheid Engineeringweek Hogeschool van AmsterdamJurjen Helmus
 
Port Of Rotterdam - Pierewaaien In De Stadshavens
Port Of Rotterdam - Pierewaaien In De StadshavensPort Of Rotterdam - Pierewaaien In De Stadshavens
Port Of Rotterdam - Pierewaaien In De StadshavensMartijn Waldram
 
Fotoalbum Boottocht Mcg 11 September 2009 4
Fotoalbum Boottocht Mcg 11 September 2009 4Fotoalbum Boottocht Mcg 11 September 2009 4
Fotoalbum Boottocht Mcg 11 September 2009 4guest7598771
 
Presentatie Allard Castelein
Presentatie Allard CasteleinPresentatie Allard Castelein
Presentatie Allard CasteleinEuropadialoog
 
Ruimte[ ]Praat. 20 augustus 2014
Ruimte[ ]Praat. 20 augustus 2014Ruimte[ ]Praat. 20 augustus 2014
Ruimte[ ]Praat. 20 augustus 2014Els Brouwers
 
Press Release 10 12 2009 Antwerp East Port
Press Release 10 12 2009 Antwerp East PortPress Release 10 12 2009 Antwerp East Port
Press Release 10 12 2009 Antwerp East Portmarcluyckx
 
Brochure-Grote Hoorn Toer 2015
Brochure-Grote Hoorn Toer 2015Brochure-Grote Hoorn Toer 2015
Brochure-Grote Hoorn Toer 2015Kitty Wiegert
 
Press Release 10 12 2009 Antwerp East Port
Press Release 10 12 2009 Antwerp East PortPress Release 10 12 2009 Antwerp East Port
Press Release 10 12 2009 Antwerp East Portguesta59b0c
 
Hv2 h6 §2
Hv2 h6 §2Hv2 h6 §2
Hv2 h6 §2bry_laky
 
15505 Cover Glossy stadshaven_NL_3 NOV
15505 Cover Glossy stadshaven_NL_3 NOV15505 Cover Glossy stadshaven_NL_3 NOV
15505 Cover Glossy stadshaven_NL_3 NOVYvette Van Dael
 
Te koop aangeboden, buiten kans voor ondernemers die zich willen vestigen in ...
Te koop aangeboden, buiten kans voor ondernemers die zich willen vestigen in ...Te koop aangeboden, buiten kans voor ondernemers die zich willen vestigen in ...
Te koop aangeboden, buiten kans voor ondernemers die zich willen vestigen in ...Dane Bedrijfsvastgoed
 
Interview Fvd Broek Binnenvaart Bd
Interview Fvd Broek Binnenvaart BdInterview Fvd Broek Binnenvaart Bd
Interview Fvd Broek Binnenvaart Bdfnvdb
 
Alle Hens nr 07 08-2012
Alle Hens nr 07 08-2012Alle Hens nr 07 08-2012
Alle Hens nr 07 08-2012Jo De Witt
 
Ontdek en proef oosteroever
Ontdek en proef oosteroeverOntdek en proef oosteroever
Ontdek en proef oosteroeverKarelDeschildre1
 

Semelhante a De Haven Van Rotterdam (18)

Hv2 h6 §1
Hv2 h6 §1Hv2 h6 §1
Hv2 h6 §1
 
S&O Marleen van de Kerkhof Duurzaamheid Engineeringweek Hogeschool van Amsterdam
S&O Marleen van de Kerkhof Duurzaamheid Engineeringweek Hogeschool van AmsterdamS&O Marleen van de Kerkhof Duurzaamheid Engineeringweek Hogeschool van Amsterdam
S&O Marleen van de Kerkhof Duurzaamheid Engineeringweek Hogeschool van Amsterdam
 
Port Of Rotterdam - Pierewaaien In De Stadshavens
Port Of Rotterdam - Pierewaaien In De StadshavensPort Of Rotterdam - Pierewaaien In De Stadshavens
Port Of Rotterdam - Pierewaaien In De Stadshavens
 
Fotoalbum Boottocht Mcg 11 September 2009 4
Fotoalbum Boottocht Mcg 11 September 2009 4Fotoalbum Boottocht Mcg 11 September 2009 4
Fotoalbum Boottocht Mcg 11 September 2009 4
 
Presentatie Allard Castelein
Presentatie Allard CasteleinPresentatie Allard Castelein
Presentatie Allard Castelein
 
Ruimte[ ]Praat. 20 augustus 2014
Ruimte[ ]Praat. 20 augustus 2014Ruimte[ ]Praat. 20 augustus 2014
Ruimte[ ]Praat. 20 augustus 2014
 
Press Release 10 12 2009 Antwerp East Port
Press Release 10 12 2009 Antwerp East PortPress Release 10 12 2009 Antwerp East Port
Press Release 10 12 2009 Antwerp East Port
 
Brochure-Grote Hoorn Toer 2015
Brochure-Grote Hoorn Toer 2015Brochure-Grote Hoorn Toer 2015
Brochure-Grote Hoorn Toer 2015
 
Press Release 10 12 2009 Antwerp East Port
Press Release 10 12 2009 Antwerp East PortPress Release 10 12 2009 Antwerp East Port
Press Release 10 12 2009 Antwerp East Port
 
Hv2 h6 §2
Hv2 h6 §2Hv2 h6 §2
Hv2 h6 §2
 
15505 Cover Glossy stadshaven_NL_3 NOV
15505 Cover Glossy stadshaven_NL_3 NOV15505 Cover Glossy stadshaven_NL_3 NOV
15505 Cover Glossy stadshaven_NL_3 NOV
 
Te koop aangeboden, buiten kans voor ondernemers die zich willen vestigen in ...
Te koop aangeboden, buiten kans voor ondernemers die zich willen vestigen in ...Te koop aangeboden, buiten kans voor ondernemers die zich willen vestigen in ...
Te koop aangeboden, buiten kans voor ondernemers die zich willen vestigen in ...
 
Interview Fvd Broek Binnenvaart Bd
Interview Fvd Broek Binnenvaart BdInterview Fvd Broek Binnenvaart Bd
Interview Fvd Broek Binnenvaart Bd
 
Alle Hens nr 07 08-2012
Alle Hens nr 07 08-2012Alle Hens nr 07 08-2012
Alle Hens nr 07 08-2012
 
Experience 2
Experience 2Experience 2
Experience 2
 
Ontdek en proef oosteroever
Ontdek en proef oosteroeverOntdek en proef oosteroever
Ontdek en proef oosteroever
 
Haven van Antwerpen
Haven van AntwerpenHaven van Antwerpen
Haven van Antwerpen
 
brochure.pdf
brochure.pdfbrochure.pdf
brochure.pdf
 

De Haven Van Rotterdam